|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||
| Receivables, prepaids and deposits | ||||||||
| Total current assets | ||||||||
| Investment in Green Technology Metals | ||||||||
| Investment in Ascend Elements | ||||||||
| Restricted cash | ||||||||
| Property, plant and equipment | ||||||||
| Other assets | ||||||||
| Exploration and evaluation assets | ||||||||
| Total non-current assets | ||||||||
| TOTAL ASSETS | ||||||||
| Accounts payable and accrued liabilities | ||||||||
| Current portion of long-term liabilities | ||||||||
| GM transaction derivative liability | ||||||||
| Loan from former parent | ||||||||
| Total current liabilities | ||||||||
| Other liabilities | ||||||||
| Decommissioning provision | ||||||||
| Total Long-term liabilities | ||||||||
| TOTAL LIABILITIES | ||||||||
| Share capital | ||||||||
| Contributed surplus and net former parent investment | ||||||||
| Deficit | ||||||||
| TOTAL SHAREHOLDERS' EQUITY | ||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||
| ASSETS | ||||||||
| Cash (Note 2) | ||||||||
| Restricted cash | ||||||||
| Receivables | ||||||||
| Prepaids and deposits | ||||||||
| Total current assets | ||||||||
| Investments measured at fair value (Note 14) | ||||||||
| Mineral properties, plant and equipment, net (Note 3) | ||||||||
| Deferred financing costs (Note 4) | ||||||||
| Other assets | ||||||||
| Total assets | ||||||||
| LIABILITIES | ||||||||
| Accounts payable | ||||||||
| Accrued liabilities (Note 6) | ||||||||
| Current portion of lease liabilities (Note 7) | ||||||||
| GM Tranche 2 liability (Note 4) | ||||||||
| Total current liabilities | ||||||||
| Convertible debt and conversion feature (Note 8) | ||||||||
| Warrant obligation (Note 4) | ||||||||
| LAC Warrants | ||||||||
| JV Warrants | ||||||||
| Total warrant obligation (Note 4) | ||||||||
| DOE Loan | ||||||||
| Royalty and production payment arrangements (Note 8) | ||||||||
| Lease liabilities (Note 7) | ||||||||
| Reclamation liabilities | ||||||||
| Other liabilities | ||||||||
| Total liabilities | ||||||||
| Non-controlling interest (Note 5) | ||||||||
| STOCKHOLDERS' EQUITY | ||||||||
| Common stock, no par value, unlimited authorized; 361,841 and 314,335 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively (Note 9) | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total stockholders' equity | ||||||||
| Total liabilities, non-controlling interest and stockholders' equity |
Loading...